XML 40 R29.htm IDEA: XBRL DOCUMENT v3.26.1

Stock Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity

The following table summarizes stock option activity during the three months ended March 31, 2026:

			Number of Shares						Weighted- Average Exercise Price
Stock options outstanding at December 31, 2025			2,478,871						$	20.47
Exercised			(28,709)						3.80
Forfeited			(176)						32.55
Expired			(16,302)						27.68
Stock options outstanding at March 31, 2026			2,433,684						20.62
Stock options exercisable at March 31, 2026			1,888,290						$	22.47

Summary of RSUs Activity

The following table summarizes restricted stock units, or RSUs, and performance restricted stock units, or PSUs, activity during the three months ended March 31, 2026:

			Number of Shares						Weighted- Average Grant Date Fair Value
RSUs and PSUs outstanding at December 31, 2025			3,930,939						$	15.54
RSUs granted			964,087						19.91
RSUs vested			(268,315)						13.72
RSUs forfeited			(141,627)						16.67
PSUs granted			546,500						20.42
PSUs vested			(118,304)						18.99
PSUs forfeited			(58,896)						18.73
RSUs and PSUs outstanding at March 31, 2026			4,854,384						$	16.89

Summary of PSUs Activity

The following table summarizes restricted stock units, or RSUs, and performance restricted stock units, or PSUs, activity during the three months ended March 31, 2026:

			Number of Shares						Weighted- Average Grant Date Fair Value
RSUs and PSUs outstanding at December 31, 2025			3,930,939						$	15.54
RSUs granted			964,087						19.91
RSUs vested			(268,315)						13.72
RSUs forfeited			(141,627)						16.67
PSUs granted			546,500						20.42
PSUs vested			(118,304)						18.99
PSUs forfeited			(58,896)						18.73
RSUs and PSUs outstanding at March 31, 2026			4,854,384						$	16.89

Summary of Expense Relating to Employee and Nonemployee Stock-Based Payment Awards from Stock Options and RSUs

The following table summarizes stock-based compensation expense relating to employee and non-employee stock-based awards for the three months ended March 31, 2026 and 2025, included in the condensed consolidated statements of operations as follows (in thousands):

			Three Months Ended March 31,
			2026						2025
Cost of testing services			$	265					$	363
Cost of product			89						231
Cost of patient and digital solutions			134						220
Research and development			1,323						1,359
Sales and marketing			1,835						2,584
General and administrative			6,157						4,174
Total			$	9,803					$	8,931

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration